David L. Mahoney, Director at CORCEPT THERAPEUTICS INC (CORT), sold 103,606 shares at $117.47 ($12.3M) on 2026-08-18, disclosed to the SEC on 2026-08-20.
Scheduled sale ($12.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $117.47 | 4,984 | $585K | 4.8% |
| 2 | $118.24 | 91,167 | $10.8M | 88.0% |
| 3 | $118.88 | 7,055 | $839K | 6.8% |
| 4 | $119.64 | 400 | $48K | 0.4% |
| Total | $118.25 avg | 103,606 | $12.3M | 100% |
| Filing → |
| CORT | SELL | 2023-08-16 | $774K | — | Filing → |
| CORT | SELL | 2017-07-20 | $575K | — | Filing → |
| CORT | SELL | 2017-07-20 | $87K | — | Filing → |